DK1343766T3 - Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner - Google Patents

Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner

Info

Publication number
DK1343766T3
DK1343766T3 DK01990192T DK01990192T DK1343766T3 DK 1343766 T3 DK1343766 T3 DK 1343766T3 DK 01990192 T DK01990192 T DK 01990192T DK 01990192 T DK01990192 T DK 01990192T DK 1343766 T3 DK1343766 T3 DK 1343766T3
Authority
DK
Denmark
Prior art keywords
naphthyridines
quinolones
cyclization
preparation
process step
Prior art date
Application number
DK01990192T
Other languages
Danish (da)
English (en)
Inventor
Sreenivasa Reddy Mundla
Jared Lynn Randall
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1343766T3 publication Critical patent/DK1343766T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01990192T 2000-12-14 2001-12-07 Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner DK1343766T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (fr) 2000-12-14 2001-12-07 Etape de processus de cyclisation dans la fabrication de quinolones et de naphthyridines

Publications (1)

Publication Number Publication Date
DK1343766T3 true DK1343766T3 (da) 2005-10-31

Family

ID=22969207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01990192T DK1343766T3 (da) 2000-12-14 2001-12-07 Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner

Country Status (19)

Country Link
EP (1) EP1343766B1 (fr)
JP (2) JP4417007B2 (fr)
KR (1) KR100603163B1 (fr)
CN (1) CN1232508C (fr)
AT (1) ATE300522T1 (fr)
AU (2) AU2905702A (fr)
BR (1) BR0116229A (fr)
CA (1) CA2427831C (fr)
CZ (1) CZ20031379A3 (fr)
DE (1) DE60112325T2 (fr)
DK (1) DK1343766T3 (fr)
ES (1) ES2247190T3 (fr)
HU (1) HUP0303991A3 (fr)
IL (2) IL155677A0 (fr)
MX (1) MXPA03005338A (fr)
NO (1) NO325236B1 (fr)
NZ (1) NZ525569A (fr)
PL (1) PL207394B1 (fr)
WO (1) WO2002048113A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
CA2470365C (fr) 2002-11-20 2011-05-17 Japan Tobacco Inc. Composes 4-oxoquinoliniques et leur utilisation comme inhibiteur de la vih-integrase
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
ES2531190T3 (es) 2006-03-06 2015-03-11 Japan Tobacco Inc Método para producir un compuesto de 4-oxoquinolina
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
TWI411602B (zh) 2006-09-12 2013-10-11 Gilead Sciences Inc 製造整合酶抑制劑的方法及彼所用的中間物
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
WO2010002415A1 (fr) 2008-07-01 2010-01-07 Taigen Biotechnology Co., Ltd. Traitement d'une infection par des bactéries résistantes aux antibiotiques
ES2608860T3 (es) 2012-08-03 2017-04-17 Gilead Sciences, Inc. Proceso e intermedios para preparar inhibidores de la integrasa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0775145A1 (fr) * 1994-08-02 1997-05-28 The Procter & Gamble Company Procede d'obtention d'antimicrobiens a base de quinolonyle lactame et nouveaux composes intermediaires
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen

Also Published As

Publication number Publication date
DE60112325D1 (de) 2005-09-01
IL155677A (en) 2009-02-11
HUP0303991A3 (en) 2012-09-28
NO20032667L (no) 2003-08-14
NO325236B1 (no) 2008-03-03
DE60112325T2 (de) 2006-05-24
EP1343766B1 (fr) 2005-07-27
CA2427831C (fr) 2009-08-18
KR100603163B1 (ko) 2006-07-24
ATE300522T1 (de) 2005-08-15
KR20030063420A (ko) 2003-07-28
PL207394B1 (pl) 2010-12-31
BR0116229A (pt) 2003-11-04
EP1343766A1 (fr) 2003-09-17
ES2247190T3 (es) 2006-03-01
CZ20031379A3 (cs) 2003-11-12
AU2002229057B2 (en) 2005-04-21
NO20032667D0 (no) 2003-06-12
AU2905702A (en) 2002-06-24
PL363355A1 (en) 2004-11-15
HUP0303991A2 (hu) 2004-04-28
IL155677A0 (en) 2003-11-23
JP2004515542A (ja) 2004-05-27
JP4417007B2 (ja) 2010-02-17
NZ525569A (en) 2004-09-24
CN1232508C (zh) 2005-12-21
CA2427831A1 (fr) 2002-06-20
CN1481365A (zh) 2004-03-10
JP2010001315A (ja) 2010-01-07
MXPA03005338A (es) 2003-10-06
WO2002048113A1 (fr) 2002-06-20

Similar Documents

Publication Publication Date Title
PT1070056E (pt) Inibidores de pde iii/iv a base de ftalazinona
NO20024869D0 (no) Oksygenatomdanningsprosess
DK1343766T3 (da) Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE411287T1 (de) Neue metallproteinaseinhibitoren
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
MY141871A (en) A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones
DK1335913T3 (da) Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
MXPA04000771A (es) Metodo para nitracion de compuestos fenolicos.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
DK1280752T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
DK1085019T3 (da) Omoprazolsyntese
SE0101323D0 (sv) New process
DK1307460T3 (da) Fremgangsmåde til fremstilling af imidazo [1,2-c][2,3]benzodiazepiner og mellemprodukter ved fremstilling af disse
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
DK1694684T3 (da) Fremgangsmåde til fremstilling af camptothecinderivater
SE0000382D0 (sv) New process
WO2003044877A3 (fr) Dispositif electroluminescent et composes utilises dans celui-ci
NO20033840D0 (no) Fremgangsmåte for fremstilling av mirtazapinmellomprodukter
DK1315702T3 (da) Fremgangsmåde til fremstilling af halogen-4-phenoxyquinoliner
DK1171542T3 (da) Fremgangsmåde til fremstilling af oxygenfjernende forseglingsmiddelsammensætninger